drugset / Trial / NCT07651488
Evaluation of Intrathecal Hyperbaric Bupivacaine With Dexmedetomidine in Adults Undergoing Perianal Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The aim of this study is to evaluate the effects of adding 5-mcg dexmedetomidine to hyperbaric bupivacaine in our population as it has never been published before, to enhance the duration of analgesia after perianal procedures requiring spinal saddle block and, thus reducing requirements of postoperative analgesics.
Timeline
- Start
- 2023-03-29
- Primary completion
- 2023-09-28
- Completion
- 2023-09-28
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dexmedetomidine | Other / unclassified | 5 ug | Intrathecal |
| Comparator | Bupivacaine | Other / unclassified | 5 mg | Intrathecal |
Indications
No indication recorded.